SYNGAP1 and Intellectual disability: Consistent with its molecular function, studies from human patients have shown that loss-of-function mutations in SYNGAP1 resulted in Intellectual Disability (ID), Autism Spectrum Disorder (ASD), and epilepsy (Hamdan et al., 2009, 2011; Rauch et al., 2012).